e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Exhaled biomarkers to assess airway inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Expiratory flow rate and breath hold affect exhaled volatile organic compounds (VOC) in healthy subjects
A. Bikov, K. Paschalaki, S. Kharitonov, R. L. Sinclair, I. Horvath, O. Usmani, P. Barnes, P. Paredi (London, Rochester, United Kingdom; Budapest, Hungary)
Source:
Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation
Session:
Exhaled biomarkers to assess airway inflammation
Session type:
Oral Presentation
Number:
4305
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bikov, K. Paschalaki, S. Kharitonov, R. L. Sinclair, I. Horvath, O. Usmani, P. Barnes, P. Paredi (London, Rochester, United Kingdom; Budapest, Hungary). Expiratory flow rate and breath hold affect exhaled volatile organic compounds (VOC) in healthy subjects. Eur Respir J 2012; 40: Suppl. 56, 4305
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003
The pH-value of exhaled breath condensate - mainly influenced by exhaled volatile compounds
Source: Eur Respir J 2005; 26: Suppl. 49, 373s
Year: 2005
Expiratory flow dependence of exhaled breath temperature in children
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010
Diet and alcohol affect exhaled volatile organic compounds (VOCs)
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Peak expiratory flow (PEF) as a predictive factor of elevated fraction exhaled nitric oxide (FENO) in young healthy swimmers in indoor chlorinated pools
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Standardization of exhaled volatile organic compounds (VOCs) measurement
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Value of exhaled volatile organic compounds in monitoring airway disease
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
Presence of volatile organic compounds (VOC) in exhaled breath in patients diagnosed with lung cancer (LC) vs healthy patients. Preliminary data
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Exhaled volatile organic compounds in nonrespiratory diseases
Source: Eur Respir Monogr 2010; 49: 140-151
Year: 2010
Oscillating postive expiratory pressure (OPEP) increases the concentration of protein in exhaled breath condensate (EBC)
Source: Eur Respir J 2005; 26: Suppl. 49, 571s
Year: 2005
The influence of active and passive air humidification on exhaled breath condensate volume
Source: ERJ Open Res, 6 (4) 00009-2020; 10.1183/23120541.00009-2020
Year: 2020
Exhaled NO, but not CO or breath condensate nitrogen products discriminate between healthy and asthmatic children
Source: Eur Respir J 2005; 26: Suppl. 49, 675s
Year: 2005
Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept